Oncology nurses' awareness of cognitive impairment secondary to chemotherapy

Clinical Journal of Oncology Nursing

Volumn 12, Issue 5, 2008, Pages 725-729

  Myers, Jamie S ^a   Teel, Cynthia ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AWARENESS; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; HUMAN; MANPOWER; NURSE; NURSING ORGANIZATION; ONCOLOGY NURSING; PILOT STUDY; PSYCHOLOGICAL ASPECT; UNITED STATES;

ANTINEOPLASTIC AGENTS; AWARENESS; COGNITION DISORDERS; HUMANS; MIDWESTERN UNITED STATES; NURSES; ONCOLOGIC NURSING; PILOT PROJECTS; SOCIETIES, NURSING;

EID: 58149302984     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/08.CJON.725-729     Document Type: Article

References (22)

1. Ahles, T.A., & Saykin, A.J. (2001). Cognitive effects of standarddose chemotherapy in patients with cancer. Cancer Investigation, 19(8), 812-820.
2. Ahles, T.A., & Saykin, A.J. (2002). Breast cancer chemotherapyrelated cognitive dysfunction. Clinical Breast Cancer Supplement, 3(Suppl. 3), S84-S90.
3. Ahles, T.A., & Saykin, A.J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192-201
4. Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L.A., Skalla, K., et al. (2002). Neuropsychologic impact of standarddose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
5. Aubin, M., Vezina, L., Parent, R., Fillion, L., Allard, P., Bergeron, R., et al. (2006). Impact of an educational program on pain management in patients with cancer living at home. Oncology Nursing Forum, 33(6), 1183-1188.
6. Belleau, F.P., Hagan, L., & Masse, B. (2001). Effects of an educational intervention on the anxiety of women awaiting mastectomies. Canadadian Oncology Nursing Journal, 11(4), 172-180.
7. Benor, D.E., Delbar, V., & Krulik, T. (1998). Measuring impact of nursing interventions on cancer patients' ability to control symptoms. Cancer Nursing, 21(5), 320-334.
8. Castellon, S.A., Ganz, P.A., Bower, J.E., Peterson, L., Abraham, L., & Greendale, G.A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26(7), 955-969.
9. Jackson, H.A. (2002). The development of an admission tool for the assessment of the palliative care symptom: Pain. Retrieved January 24, 2008, from http://www.ons.org/outcomes/measures/survey.shtml
10. Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncology Nursing Forum, 32(6), 1151-1163.
11. th ed., pp. 959-970). Hamilton: B.C. Decker, Inc.
12. Kreukels, B.P., Schagen, S.B., Ridderinkhof, K.R., Boogerd, W., Hamburger, H.L., Muller, M.J., et al. (2006). Effects of high-dose and conventional-dose adjuvant chemotherapy on long-termcognitive sequelae in patients with breast cancer: An electrophysiologic study. Clinical Breast Cancer, 7(1), 67-78.
13. Mancuso, A., Migliorino, M., De Santis, S., Saponiero, A., & De Marinis, F. (2006). Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of Oncology, 17(1), 146-150.
14. Massa, E., Madeddu, C., Lusso, M.R., Gramignano, G., & Mantovani, G. (2006). Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. CriticalReviews in Oncology/Hematology, 57(2), 175-182.
15. Oncology Nursing Society. (2006). Oncology services in the ambulatory setting [Position statement]. Retrieved August 8, 2007, from http://www.ons.org/publications/positions/RevAmbulatoryPractice.shtml
16. O'Shaughnessy, J. (2003). Chemotherapy-related cognitive dysfunction in breast cancer. Seminars in Oncology Nursing,19(4, Suppl. 2), 17-24.
17. Polovich, M., Olsen, M., & Whitford, J. (Eds.). (in press). Chemotherapy and biotherapy guidelines and recommendations for practice (3rd ed.). Pittsburgh, PA: Oncology Nursing Society.
18. Schagen, S.B., Muller, M.J., Boogerd, W., & van Dam, F.S. (2002).Cognitive dysfunction and chemotherapy: Neuropsychological findings in perspective. Clinical Breast Cancer, 3(Suppl. 3),S100-S108.
19. Shapiro, P.J., Jacobs, L.A., Palmer, S.C., Coyne, J.C., Meadows, A.T., & Vaughn, D.J. (2005). Neurocognitive function (NCF) in long-term survivors of testicular cancer (TC) [Abstract 8034]. Journal of Clinical Oncology, 23(16, Suppl.), 737s.
20. Smith, J., Forster, A., & Young, J. (2004). A randomized trial to evaluate an education programme for patients and carers after stroke. Clinical Rehabilitation, 18(7), 726-736.
21. Troy, L., McFarland, K., Littman-Power, S., Kelly, B.J., Walpole, E.T., Wyld, D., et al. (2000). Cisplatin-based therapy: A neurological and neuropsychological review. Psycho-Oncology,9(1), 29-39.
22. Wefel, J.S., Lenzi, R., Theriault, R.L., Davis, R.N., & Meyers, C.A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer, 100(11), 2292-2299.